Storyline

New computational methods advance drug discovery and molecular glue degrader design

Two recent studies introduce innovative computational approaches to accelerate drug development.

Evidence locked
Today's free sample is only available for the edition's flagship storyline.
Evidence preview
  • Integrated proteomic screening reveals design principles of CRBN molecular glue degraders
    bioRxiv (all subjects)